StockData
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW

Abpro Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.41+0.00 (+0.11%)

Close on Oct 19, 2026

Market cap
$2.41M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Abpro has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Abpro filed with the SEC